1. LB0006 SUBCUTANEOUS SECUKINUMAB 300MG AND 150MG PROVIDES SUSTAINED INHIBITION OF RADIOGRAPHIC PROGRESSION IN PSORIATIC ARTHRITIS OVER 2 YEARS: RESULTS FROM THE PHASE 3 FUTURE-5 TRIAL. (June 2019) Authors: Mease, Philip J.; B.M. Landewé, Robert; Rahman, Proton; Tahir, Hasan; Singhal, Atul; Boettcher, Elke; Navarra, Sandra; Readie, Aimee; Mpofu, Shephard; Maria Delicha, Eumorphia; Pricop, Luminita; van der Heijde, Désirée Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗